PM
INSIDER · HALO · HALOZYME THERAPEUTICS, INC. · DIRECTOR
Posard Matthew L.
Every open-market transaction filed under this name, Sep 16 to Oct 1.
Filings
8
0 buys · 8 sells
Bought
—
open market, at cost
Sold
$2.6M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 1 | HALO | HALOZYME THERAPEUTICS, INC. | Director | Sell | 100 | $110.04 | $11K | — |
| Oct 1 | HALO | HALOZYME THERAPEUTICS, INC. | Director | Sell | 1,100 | $109.57 | $121K | — |
| Oct 1 | HALO | HALOZYME THERAPEUTICS, INC. | Director | Sell | 3,300 | $108.45 | $358K | — |
| Oct 1 | HALO | HALOZYME THERAPEUTICS, INC. | Director | Sell | 730 | $107.17 | $78K | — |
| Sep 16 | HALO | HALOZYME THERAPEUTICS, INC. | Director | Sell | 4,000 | $108.99 | $436K | — |
| Sep 16 | HALO | HALOZYME THERAPEUTICS, INC. | Director | Sell | 8,896 | $108.04 | $961K | — |
| Sep 16 | HALO | HALOZYME THERAPEUTICS, INC. | Director | Sell | 3,000 | $106.83 | $320K | — |
| Sep 16 | HALO | HALOZYME THERAPEUTICS, INC. | Director | Sell | 3,100 | $106.13 | $329K | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.